-
Trapped seafarers traumatised by Gulf fighting: charities
-
European minnows bid to challenge social media giants
-
Red-hot Knicks open 3-0 playoff lead against Sixers
-
At 100th major, Aussie Scott sees best as yet to come
-
Scheffler and McIlroy fancied for PGA Championship title
-
Acting US attorney general pursues Trump grievances at Justice Dept
-
Spirit exit likely to lead to higher US airfares, experts say
-
World Cup to hold trio of star-studded opening ceremonies
-
Defending champ Jeeno grabs three-shot lead at windy Mizuho Americas Open
-
McIlroy says PGA should be open to returns from LIV Golf
-
Im leads Fleetwood by one at Quail Hollow
-
Peru presidential hopeful says electoral 'coup' underway
-
Mexico to cut school year short ahead of World Cup
-
Lens secure Champions League spot and send Nantes down
-
Dortmund down Frankfurt to push Riera close to the edge
-
Costa Rica's new leader vows 'firm land' against drug gangs
-
Messi says Argentina up against 'other favorites' in World Cup repeat bid
-
Global stocks diverge, oil rises as fresh US-Iran clashes hit peace hopes
-
Ailing Djokovic falls to early Italian Open exit ahead of Roland Garros
-
Costa Rica leader sworn in with tough-on-crime agenda
-
UK PM Starmer vows to fight on after local polls drubbing
-
Formula One engines to change again in 2027
-
Djokovic falls in Italian Open second round to qualifier Prizmic
-
NFL reaches seven-year deal with referees
-
Real Madrid fine Tchouameni and Valverde 500,000 euros over bust-up
-
Hantavirus scare revives Covid-era conspiracy theories
-
Report revives speculation China Eastern crash was deliberate
-
Allen ton powers Kolkata to fourth win in a row in IPL
-
Zarco dominates Le Mans qualifying as Marquez struggles
-
'Worst whistle' - Lakers coach blasts refs over LeBron treatment
-
French couple from virus-hit ship describe voyage as 'unlikely adventure'
-
Van der Breggen soars into women's Vuelta lead with stage six win
-
WHO says hantavirus risk low as countries prep repatriation flights
-
Stocks diverge, oil rises as fresh US-Iran clashes hit peace hopes
-
Zverev and Swiatek move into Italian Open third round
-
Celtic driven by fear of failure in Hearts chase, says O'Neill
-
Selling factories to Chinese partners: risky road for European carmakers
-
Rubio urges Europeans to share the Iran burden
-
France's Magnier sprints to victory in crash-hit Giro opener
-
Is there anybody out there? Pentagon releases secret UFO files
-
US job growth beats expectations but consumer confidence at all-time low
-
US fires on Iran tankers as talks hang in balance
-
German sports car maker Porsche to cut 500 jobs
-
Nuno not focused on own future during West Ham relegation fight
-
US job growth consolidates gains, beating expectations in April
-
Rising fuel prices strand hundreds of Indonesian fishermen
-
US expecting Iran response on deal despite naval clash
-
Stocks diverge, oil steady as fresh US-Iran clashes hit peace hopes
-
Arteta calls for Arsenal focus on 'huge' West Ham clash
-
EU opens door to using US jet fuel as shortages loom
Google AI tool predicts danger of genetic mutations
Researchers at Google DeepMind, the tech giant's artificial intelligence arm, on Tuesday introduced a tool that predicts whether genetic mutations are likely to cause harm, a breakthrough that could help research into rare diseases.
The findings are "another step in recognising the impact that AI is having in the natural sciences," said Pushmeet Kohli, vice president for research at Google DeepMind.
The tool focuses on so-called "missense" mutations, where a single letter of the genetic code is affected.
A typical human has 9,000 such mutations throughout their genome; they can be harmless or cause diseases such as cystic fibrosis or cancer, or damage brain development.
To date, four million of these mutations have been observed in humans, but only two percent of them have been classified, either as disease-causing or benign.
In all, there are 71 million such possible mutations. The Google DeepMind tool, called AlphaMissense, reviewed these mutations and was able to predict 89 percent of them, with 90 percent accuracy.
A score was assigned to each mutation, indicating the risk of it causing disease (otherwise referred to as pathogenic).
The result: 57 percent were classified as probably benign, and 32 percent as probably pathogenic -- the remainder being uncertain.
The database was made public and available to scientists, and an accompanying study was published on Tuesday in the journal Science.
AlphaMissense demonstrates "superior performance" than previously available tools, wrote experts Joseph Marsh and Sarah Teichmann in an article also published in Science.
"We should emphasize that the predictions were never really trained or never really intended to be used for clinical diagnosis alone," said Jun Cheng of Google DeepMind.
"However, we do think that our predictions can potentially be helpful to increase the diagnosed rate of rare disease, and also potentially to help us find new disease-causing genes," Cheng added.
Indirectly, this could lead to the development of new treatments, the researchers said.
The tool was trained on the DNA of humans and closely-related primates, enabling it to recognize which genetic mutations are widespread.
Cheng said the training allowed the tool to input "millions of protein sequences and learns what a regular protein sequence looks like."
It then could identify a mutation and its potential for harm.
Cheng compared the process to learning a language.
"If we substitute a word from an English sentence, a person that is familiar with English can immediately see whether this word substitution will change the meaning of the sentence or not."
C.Garcia--AMWN